Despite an increase in interested donors, the shortage of Organs has worsened. For example, about 80 000 persons in the United States awaiting an organ transplant from July 2000 to July 2001, with less than a third receiving one. The answer to this problem, like other big engineering challenges, necessitates long-term solutions involving the construction or manufacture of living organs from a person's own cells. Tissue engineering has evolved over the last three decades as a multidisciplinary subject comprising scientists, engineers, and clinicians with the goal of generating biological substitutes that replicate natural tissue to replace damaged tissues or restore organ function. Tissue engineering and regenerative medicine, which aim to create functioning tissue-constructs that mimic native tissue for the repair and/or replacement of damaged tissues or complete organs, have progressed quickly in recent decades. Traditional tissue engineering procedures, which use scaffolds, growth factors, and cells, have had little success in fabricating complicated 3D structures and in vivo organ regeneration, making them logistically and economically unsuitable for clinical use.
Title : Side effect free cancer chemotherapy by directed gene delivery using nanomaterials
A C Matin, Stanford University School of Medicine, United States
Title : Artificial intelligence (AI) in biomedical engineering
Hossein Hosseinkhani, Innovation Center for Advanced Technology, Matrix HT, United States
Title : Novel gene therapy options for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Challenges in skeletal tissue engineering
Patrizia Ferretti, UCL Great Ormond Street Institute of Child Health, United Kingdom
Title : Electroactive polymer-based smart scaffolds for tissue engineering and regenerative medicine
Federico Carpi, University of Florence, Italy
Title : Cellular and molecular profiling of critical bone fractures in axolotl
Polikarpova Anastasia, The Institute of Molecular Pathology, Austria